February 2023 - Page 4 of 18

ThursdayFeb 23, 2023 10:30 am

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) CEO Joins Investor Webinar, Details Corporate Expansion Plans

EverGen Infrastructure CEO, Chase Edgelow recently joined a webinar hosted by Adelaide Capital to provide investors and stakeholders with an update on the company’s operations Edgelow elaborated on the company’s portfolio, including its 4 existing revenue generating assets, 2 projects currently under construction as well as its Ontario-based Greenfield project, Project Radius By 2Q 2023, EverGen anticipated that the completion of its RNG projects would drive gross generating capacity to 240,000 GJ/annum, whilst growing EBITDA by $5-7m per year In the longer term, successful execution on EverGen’s Ontario-based Greenfield project could see the company expand its RNG production by as…

ThursdayFeb 23, 2023 10:02 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Plan to Streamline Efforts, Maximize Efficiency, Focus on Clinical Trials

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has announced a strategic plan designed to streamline efforts, maximize operating efficiency and focus on critical clinical trials, including near-term, mid-term and long-term milestones. A part of that plan was the release of an estimated 15% of Cybin’s workforce, including those in roles that were identified as not a clinical priority or not directly involved with any clinical trial initiatives. This move alone is expected to generate cost savings by reducing operating expenses. The announcement noted that with the anticipated cost savings from the overall streamlining…

ThursdayFeb 23, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking Forward to 2023 Goals for Patented DehydraTECH(TM) Technology

Lexaria’s 2022 R&D efforts saw high levels of success, establishing the company as one of the world’s leaders in the investigation of CBD for controlling human blood pressure and, separately, demonstrating performance enhancements compared to one of the world's leading anti-seizure medications During Q1 2023, Lexaria expects to provide additional results from its hypertension study HYPER-H21-4; complete dosing in the company’s animal dementia and diabetes studies; complete dosing in the human nicotine study NIC-H21-1; and submit and publish additional results in research journals Lexaria’s DehydraTECH technology currently has 28 granted patents, with many more pending patents in countries worldwide Lexaria…

ThursdayFeb 23, 2023 9:00 am

USMCA Developed to Bolster North American Export Services, with Freight Technologies Inc. (NASDAQ: FRGT) to Capitalize on It

Export services under NAFTA, mainly covering transportation, travel, business, and financial services, increased from $14.7 billion in 1999 to $30.4 billion in 2021 With the transition from NAFTA to USMCA, trade in goods and services is set to see a spike from 2022 going forward, and Fr8Tech expects to capitalize on this Freight Technologies Inc., with its superior freight platform for North American cross-border shipping, yielded a 45% YOY revenue growth for Q2 2022, which it looks to surpass in the subsequent quarters of the current financial year With trucks moving about 70% of North American surface trade by value,…

WednesdayFeb 22, 2023 2:11 pm

QualityStocksNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Deploying Clean Energy Generation and Energy Efficiency Solutions at Scale

Correlate Infrastructure Partners (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, is focused on retrofitting existing commercial buildings with renewable energy solutions, thereby reducing their carbon footprint and overall energy consumption. “Through its industry-leading energy solution and financing platform for the commercial and industrial sectors, Correlate is helping to reduce site-specific energy use. It does so while also deploying clean energy generation and energy efficiency solutions at scale, ultimately helping mitigate the effects of climate change,” a recent article reads. “With a significant amount of a building’s energy spent on heating, cooling…

WednesdayFeb 22, 2023 1:42 pm

QualityStocksNewsBreaks – Coyuchi Inc. Leveraging Omnichannel and Circular Business Model to Disrupt Organic Textile Market

Coyuchi, the gold standard in sustainable luxury home goods, has been driven by four foundational pillars: protecting the planet, innovating circular design, sustainable living, and community enrichment. “Coyuchi’s line of products includes luxury organic bedding, sheets, towels, apparel, and other home goods, which are produced using 100% organic cotton materials. With a seasoned leadership team, a robust e-commerce shopping experience, and a healthy customer base, Coyuchi is preparing to enter a new phase of growth as the world awakens to sustainability at scale… Coyuchi continues to push the organic textile market forward through its circular initiatives and supporting cross-industry sustainability.…

WednesdayFeb 22, 2023 12:16 pm

QualityStocksNewsBreaks – SideChannel Inc. (SDCH) CEO Says Cannabis Companies Must Catch up in Benzinga Article

SideChannel (OTCQB: SDCH), a provider of cybersecurity products and services to emerging, middle-market and enterprise companies, was featured in a recent Benzinga article. The piece, titled “EXCLUSIVE: Ex-KGB Cyber Criminals with Ties to Moscow Could Steal Your Cannabis Business Info & Money, Expert Warns,” includes excerpts from an exclusive interview with SDCH founder and CEO Brian Haugli. “Forget the evil nerd in a dark basement. That’s Hollywood. Most likely, if you’re in the cannabis industry, your hackers are part of global organizations that have turned hacking into a lean, mean money-making machine,” the article reads. “Haugli explained that cannabis companies…

WednesdayFeb 22, 2023 11:15 am

Alternative Products Expo Announces Its Upcoming Fort Lauderdale 2023 Show

Alternative Products Expo has just announced its next show, which will take place on March 3-5, 2023, in the beautiful city of Fort Lauderdale, Florida. This one-of-a-kind trade show promises to provide attendees with a unique experience that breaks away from the monotony of traditional events. It's a must-attend for anyone in the smoke shop and counterculture industry. Known for short as Alt Pro Expo, this event has its roots in the Vape and CBD world and has since expanded to include a plethora of industries. With over 200 exhibitors representing various product categories, such as Vape, CBD, Hemp, Delta-8,…

WednesdayFeb 22, 2023 10:30 am

The 3rd Annual Mining Journal Select Event: Exceptional Investment Opportunities Selected By Mining Journal

Institutional and professional investors as well as mining experts, businesses, and professionals are invited to attend the Mining Journal Select Show on March 27-28th, 2023. An exclusive lineup of presenters will pitch their businesses in front of industry leaders and investors and get an opportunity for one-on-one meetings and personalized discussions with these eminent investment groups.These mining companies presenting at Mining Journal Select are selected by the Mining Journal Research & Intelligence Team, who conduct research and analysis to shortlist a curated list of companies with exceptional potential and prospects. Investors looking for robust investment avenues can leverage this forum…

WednesdayFeb 22, 2023 9:45 am

Silo Pharma Inc. (NASDAQ: SILO) Granted US Patent For SPC-15 to Prevent and Treat Stress-Induced Disorders

SILO issued US Patent by USPTO titled “Pharmacological Prophylactics Against Stress-Induced Affective Disorders In Females” Claims allowed by patent protect use of SPC-15 for treating stress-induced affective disorders, including anxiety and PTSD Other therapeutics in company pipeline include SPU-16 to treat multiple sclerosis, SPU-21 to treat rheumatoid arthritis, SPC-14 to treat Alzheimer’s disease Therapeutics developed by SILO may qualify for FDA’s streamlined 505(b)(2) regulatory drug approval pathway Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, was recently issued US Patent 11,491,120 by the US Patent and Trademark Office (“USPTO”) (https://ibn.fm/rMLOR). The…

Site Search

Company Search

Month: February 2023